Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Selling, General & Administrative of $88 million for Q2 2026, up 1.1% from $87 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Ultragenyx Pharmaceutical was $350.56 million, up 4.3% year-over-year; for FY2025, it was $349 million, up 8.7% from FY2024.
- Annual Selling, General & Administrative has increased for 13 consecutive years, with a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Selling, General & Administrative was $321 million in FY2024 (+3.5%), $310 million in FY2023 (+11.5%), $278.14 million in FY2022 (+26.4%) and $219.98 million in FY2021 (+20.3%).
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last eight quarters, with growth averaging 6.3% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2022, with growth of 29.6%; the weakest was Q2 2024, with a decline of 1.0%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $88 million (Q1 2026), $87.94 million (Q4 2025) and $86.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | 88.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.00 Mn |
| Mar 31, 2026 | 88.00 Mn |
| Dec 31, 2025 | 87.94 Mn |
| Sep 30, 2025 | 86.62 Mn |
| Jun 30, 2025 | 87.00 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 81.89 Mn |
| Sep 30, 2024 | 80.35 Mn |
| Jun 30, 2024 | 80.60 Mn |
| Mar 31, 2024 | 78.16 Mn |
| Dec 31, 2023 | 77.03 Mn |
| Sep 30, 2023 | 74.92 Mn |
| Jun 30, 2023 | 81.40 Mn |
| Mar 31, 2023 | 76.65 Mn |
| Dec 31, 2022 | 72.85 Mn |
| Sep 30, 2022 | 69.84 Mn |
| Jun 30, 2022 | 68.14 Mn |
| Mar 31, 2022 | 67.31 Mn |
| Dec 31, 2021 | 59.43 Mn |
| Sep 30, 2021 | 53.88 Mn |
API Access
Ultragenyx Pharmaceutical Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();